2105-AF26 202404 Unified Agenda of Federal Regulatory and Deregulatory Actions 2105 Office of the Secretary OST 2100 Department of Transportation DOT Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Adding and Removing of Certain Schedule II Drugs to the Department of Transportation's Drug Testing Panel

This rulemaking would adopt the drug testing panel identified by the U.S. Department of Health and Human Services (HHS) in their urine and oral fluid Mandatory Guidelines for Federal Workplace Drug Testing Programs by proposing to amend the Department of Transportation's Drug Testing Panel in 49 CFR Part 40 by adding Fentanyl and norfentanyl (Schedule II drugs) and removing Methylenedioxyamphetamine (MDA) and Methylenedioxymethamphetamine (MDMA).

]]> Substantive, Nonsignificant First Time Published in The Unified Agenda Long-Term Actions No No 49 CFR 40 Not Yet Determined No Next Action Undetermined To Be Determined No No None No No www.regulations.gov www.regulations.gov No No Bohdan Baczara 2105 Office of the Secretary OST 202 366-6364 202 366-3897 bohdan.baczara@dot.gov 1200 New Jersey Avenue SE, Washington DC 20590